Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP+AS vs SP+AS+PQ for Low Density Malaria Clearance
NCT00330902Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of primaquine in Plasmodium falciparum malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: P.falciparum parasitaemia detected by PCR at 14 days. Started Jan 2004; status: completed.
02
Drugs
primaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00330902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330902.